RHOXF2: A Potential Drug Target and Biomarker for AL590526 (G84528)

Target Name: RHOXF2

NCBI ID: G84528

RHOXF2

RHOXF2: A Potential Drug Target and Biomarker for AL590526

Rho-associated homeobox (RhoHB) genes are a family of transmembrane proteins that play a crucial role in cell-cell adhesion, signaling, and development. RhoHB proteins have been implicated in various diseases, including cancer, neurodegenerative diseases, and developmental disorders. The RhoHB gene has four splice variants, AL590526 being one of them. This gene has not been well studied, and its functions and potential drug targets are not well understood. In this article, we will explore the RhoHB protein from AL590526 and its potential as a drug target.

Structure and Function

The RhoHB gene is a member of the Rho family of cytoskeletal proteins, which are involved in the regulation of cell-cell adhesion. The Rho family consists of six genes (RhoA, RhoB, RhoC, RhoD, RhoE, and RhoF) that share a conserved catalytic core. These genes encode a characteristic protein domain, which includes a GTP-binding site, a nucleotide-binding oligomerization (NBO) domain, and a carboxy-terminal hypervariable region (HVR).

The RhoHB protein is a 21-kDa transmembrane protein that contains 251 amino acid residues. It has a unique N-terminal region, which includes a 21-kDa N-terminal domain and a 93-amino acid residue tail. The N-terminal domain is characterized by a conserved nucleotide-binding oligomerization (NBO) domain, which is responsible for the protein's N-terminal localization to the cytoplasm. The RhoHB protein also has a unique C-terminal region, which includes a GTP-binding site and a carboxy-terminal HVR.

The RhoHB protein is involved in various cellular processes, including cell-cell adhesion, migration, and signaling. It has been shown to play a role in the regulation of cell-cell adhesion by interacting with various cell surface molecules, such as cadherins, vimentin, and E-cadherin. The RhoHB protein has also been shown to be involved in cell migration, as it has been shown to regulate the migration of cancer cells.

In addition to its role in cell-cell adhesion and migration, the RhoHB protein has also been shown to play a role in signaling. It has been shown to play a negative role in the regulation of T-cell receptor (TCR) signaling, as well as in the regulation of cell proliferation.

Potential Drug Target

The RhoHB protein is a potential drug target due to its various functions and unique structure. Its N-terminal NBO domain and C-terminal HVR make it a potential target for small molecules. Additionally, the RhoHB protein's GTP-binding site and its role in regulating cell-cell adhesion make it a potential target for antibodies or other protein-based therapeutics.

In conclusion, the RhoHB protein from AL590526 is a unique and highly conserved protein that has various functions in cell signaling and adhesion. Its N-terminal NBO domain and C-terminal HVR make it a potential target for small molecules, and its role in regulating T-cell receptor (TCR) signaling and cell-cell adhesion make it a potential target for antibodies or other protein-based therapeutics. Further research is needed to fully understand the functions and potential drug targets of the RhoHB protein from AL590526.

Protein Name: Rhox Homeobox Family Member 2

Functions: Transcription factor maybe involved in reproductive processes. Modulates expression of target genes encoding proteins involved in processes relevant to spermatogenesis

The "RHOXF2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RHOXF2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets